- £105.46m
- £88.06m
- $36.79m
- 98
- 11
- 96
- 81
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 33.9 | 30.3 | 30 | 34.4 | 36.8 |
Cost of Revenue | |||||
Gross Profit | 24 | 21.2 | 20.9 | 24.9 | 27.7 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 27.5 | 27.8 | 28.2 | 33 | 35.5 |
Operating Profit | 6.38 | 2.42 | 1.77 | 1.33 | 1.33 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 6.41 | 2.46 | 1.71 | 1.23 | 1.35 |
Provision for Income Taxes | |||||
Net Income After Taxes | 6.92 | 2.05 | 1.5 | 0.817 | -0.877 |
Net Income Before Extraordinary Items | |||||
Net Income | 6.92 | 2.05 | 1.5 | 0.817 | -0.877 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 6.92 | 2.05 | 1.5 | 0.817 | -0.877 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.65 | 0.192 | 0.141 | 0.075 | -0.083 |
Dividends per Share |